10 Panel Drug Test Flat Sided Cup CLIA Waived with EDDP and Adulterants 25/Box
Brand : Healgen Scientific
- SKU:
- HCDOAF-22105SA3
10 Panel CLIA Waived Flat Sided Multi-Panel Drug Screening Test Cup with Adulterants and Low Cut-offs
This Cost Effective High Quality CLIA Waived drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need of instrumentation. The 12-Panel Drug Test Cup is a No Step, fully integrated self contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This non-branded cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine. The Flat side enables photocopying of results.
Features & Benefits
- CLIA Waived
- FDA 510(K) Approved
- Health Canada Approved
- Sold in boxes of 25 tests
- New "Click Seal" cap!
- No step cup
- Flat Sided for copying results
- Up to 99% Accurate
- Dual scale Temperature Strip verifies if urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy to open top for the confirmation lab
Download & Print Reference Materials
Multi-Panel CLIA Waived Drug Test Package Insert
Multi-Panel CLIA Waived Drug Test Instruction Sheet
Ten Panel Configuration (Choose Panel Above) | |||
Item Number | Drugs Tested | Adulterants Tested | Approvals |
HCDOAF-22105SA3 | AMP500, BUP10, BZO300, COC150, EDDP300, MDMA500, MET500, MTD300, OPI300, OXY100 | OX - Oxidants SG - Specific Gravity PH - pH Leve |
FDA 510(k) Cleared CLIA Waived FDA Over the Counter Approved (OTC) Health Canada Approved |
SAMHSA Approved CLIA Waived Urine Drug Panel Options | |||||
Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time* | Maximum Detection Time* | Calibrator |
Amphetamine | AMP | 500 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
Cocaine | COC | 150 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | D,L- Methylenedioxy-methamphetamine |
Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-Δ9-THC-9 COOH |
Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
Methamphetamine | mAMP / MET | 500 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
* Detection times are not guaranteed. Reference configuration above for included drug panels. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. |